Mohammad Siahpush1, Gopal K Singh2, Melissa Tibbits1, Courtney A Pinard3, Raees A Shaikh1, Amy Yaroch3. 1. Department of Health Promotion, Social and Behavioral Health, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA. 2. Division of Epidemiology, U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA)/Maternal and Child Health Bureau, Rockville, Maryland, USA. 3. Gretchen Swanson Center for Nutrition, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Abstract
OBJECTIVE: The aim of this research was to compare the risk of all-cause mortality and mortality from all cancers combined, lung cancer, respiratory diseases, cardiovascular diseases and diabetes mellitus between normal-weight smokers and overweight or obese ex-smokers. METHODS: Data were from 1997 to 2004 National Health Interview Survey (with response rates ranging from 70% to 80%) which were linked to records in the National Death Index. Mortality follow-up was through 31 December 2006. The sample was limited to normal-weight smokers and overweight/obese ex-smokers 25 years of age and older (n=52,819). HR from Cox regression was computed to represent mortality effect. RESULTS: Results showed that in both women and men, normal-weight smokers, relative to overweight or obese ex-smokers, had a higher risk of mortality from all causes combined, all cancers combined, lung cancer, cardiovascular and respiratory diseases. Among women, there was no difference in mortality risk from diabetes mellitus between normal-weight smokers and overweight or obese ex-smokers. Among men, there was some evidence that the risk of mortality was higher in obese ex-smokers than normal-weight smokers. CONCLUSIONS: This article concludes that, overall, mortality risk is smaller in overweight or obese ex-smokers than normal-weight smokers. Smoking cessation interventions can tailor messages that highlight the greater reduction in mortality associated with quitting, compared with potential weight gain. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: The aim of this research was to compare the risk of all-cause mortality and mortality from all cancers combined, lung cancer, respiratory diseases, cardiovascular diseases and diabetes mellitus between normal-weight smokers and overweight or obese ex-smokers. METHODS: Data were from 1997 to 2004 National Health Interview Survey (with response rates ranging from 70% to 80%) which were linked to records in the National Death Index. Mortality follow-up was through 31 December 2006. The sample was limited to normal-weight smokers and overweight/obese ex-smokers 25 years of age and older (n=52,819). HR from Cox regression was computed to represent mortality effect. RESULTS: Results showed that in both women and men, normal-weight smokers, relative to overweight or obese ex-smokers, had a higher risk of mortality from all causes combined, all cancers combined, lung cancer, cardiovascular and respiratory diseases. Among women, there was no difference in mortality risk from diabetes mellitus between normal-weight smokers and overweight or obese ex-smokers. Among men, there was some evidence that the risk of mortality was higher in obese ex-smokers than normal-weight smokers. CONCLUSIONS: This article concludes that, overall, mortality risk is smaller in overweight or obese ex-smokers than normal-weight smokers. Smoking cessation interventions can tailor messages that highlight the greater reduction in mortality associated with quitting, compared with potential weight gain. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Ce Shang; Frank J Chaloupka; Geoffrey T Fong; Mary Thompson; Mohammad Siahpush; William Ridgeway Journal: Tob Control Date: 2015-02-02 Impact factor: 7.552
Authors: Francisco I Salgado García; Karen J Derefinko; Zoran Bursac; Robert C Klesges; Jon O Ebbert; Catherine R Womack; Rebecca A Krukowski Journal: Contemp Clin Trials Date: 2018-11-13 Impact factor: 2.226
Authors: David R Strong; Sean P David; Elaine C Johnstone; Paul Aveyard; Michael F Murphy; Marcus R Munafò Journal: Nicotine Tob Res Date: 2014-12-06 Impact factor: 4.244
Authors: James H Stein; Asha Asthana; Stevens S Smith; Megan E Piper; Wei-Yin Loh; Michael C Fiore; Timothy B Baker Journal: PLoS One Date: 2014-06-03 Impact factor: 3.240